Federated Hermes
CATX icon

Federated Hermes’s Perspective Therapeutics CATX Stock Holding History

Federated Hermes’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$740K Sell
217,023
-5,119
-2% -$19.3K ﹤0.01% 1222
2026
Q1 		$926K Buy
222,142
+8,383
+4% +$35.4K ﹤0.01% 1136
2025
Q4 		$588K Buy
213,759
+15,568
+8% +$44.4K ﹤0.01% 1264
2025
Q3 		$680K Buy
198,191
+3,111
+2% +$11.3K ﹤0.01% 1261
2025
Q2 		$671K Buy
195,080
+60,019
+44% +$158K ﹤0.01% 1253
2025
Q1 		$288K Buy
+135,061
New +$405K ﹤0.01% 1436

Other funds holding CATX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Federated Hermes's CATX Position: Q2 2026 in Review

Federated Hermes reduced its Perspective Therapeutics (CATX) stake by 2.3% in Q2 2026, selling an estimated $19.3K and leaving 217,023 shares worth $740K. The position accounts for ﹤0.01% of the portfolio, ranked #1222.

Federated Hermes first reported a position in CATX in Q1 2025 and has held it in 6 quarters since. The position peaked at $926K in Q1 2026. 131 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

  • Federated Hermes held 217,023 shares of Perspective Therapeutics worth $740K as of Q2 2026.
  • Federated Hermes sold 5,119 Perspective Therapeutics shares in Q2 2026, an estimated $19.3K.
  • Perspective Therapeutics made up ﹤0.01% of Federated Hermes's portfolio in Q2 2026, its #1222 holding.
  • Federated Hermes first reported a position in Perspective Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • Federated Hermes's Perspective Therapeutics position peaked at $926K in Q1 2026.
  • 131 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.